Rac1 regulates platelet microparticles formation and rheumatoid arthritis deterioration

Reference

• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384. doi:10.1172/JCI27196
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429–442. doi:10.1038/nri2094
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Pretorius E, Kitas GD. Platelets in rheumatic diseases: friend or foe? Curr Pharm Des 2014; 20: 552–566.
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 2011; 31: 153–164. doi:10.1007/s00296-010-1446-x
   PubMed Web of Science ®Google Scholar
• Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt, ME, Massarotti, EM, Remold-O’Donnell, E, Farndale, RW, Ware, J, Lee, DM. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580–583. doi:10.1126/science.1181928
   PubMed Web of Science ®Google Scholar
• Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002; 46: 1498–1503. doi:10.1002/art.10312
   PubMed Web of Science ®Google Scholar
• Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121–1132.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley, RE, Ahn, YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993; 72: 295–304.
   PubMed Web of Science ®Google Scholar
• Katopodis JN, Kolodny L, Jy W, Horstman LL, De Marchena EJ, Tao, JG, Haynes, DH, Ahn, YS. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997; 54: 95–101.
   PubMed Web of Science ®Google Scholar
• Holme PA, Orvim U, Hamers MJ, Solum NO, Brosstad FR, Barstad, RM, Sakariassen, KS. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646–653.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi, H, Komiyama, Y, Fujimura, Y, Ikeda, Y, Fukuhara, S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456–3464.
   PubMed Web of Science ®Google Scholar
• Merten M, Pakala R, Thiagarajan P, Benedict CR. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999; 99: 2577–2582.
   PubMed Web of Science ®Google Scholar
• Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005; 15: 163–171. doi:10.1016/j.tcb.2005.01.002
   PubMed Web of Science ®Google Scholar
• Genot EM, Arrieumerlou C, Ku G, Burgering BM, Weiss A, Kramer, IM. The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase. Mol Cell Biol 2000; 20: 5469–5478.
   PubMed Web of Science ®Google Scholar
• Marinari B, Costanzo A, Viola A, Michel F, Mangino G, Acuto, O, Levrero, M, Piccolella, E, Tuosto, L. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur J Immunol 2002; 32: 447–456. doi:10.1002/1521-4141(200202)32:2<447::AID-IMMU447>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Okada H, Jiang A, Kurosaki M, Greenberg S, Clark, EA, Kurosaki, T. Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med 1998; 188: 1287–1295.
   PubMed Web of Science ®Google Scholar
• Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu, N, Miki, T, Gutkind, JS. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995; 81: 1137–1146.
   PubMed Web of Science ®Google Scholar
• van Wetering S, van den Berk N, van Buul JD, Mul FP, Lommerse I, Mous, R., ten Klooster, J-P, Zwaginga, J-J, Hordijk, PL. VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol 2003; 285: C343–C352. doi:10.1152/ajpcell.00048.2003
   PubMed Web of Science ®Google Scholar
• Nijhara R, van Hennik PB, Gignac ML, Kruhlak MJ, Hordijk PL, Delon, J, Shaw, S. Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes. J Immunol 2004; 173: 4985–4993.
   PubMed Web of Science ®Google Scholar
• Guo F, Cancelas JA, Hildeman D, Williams DA, Zheng Y. Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development. Blood 2008; 112: 1767–1775. doi:10.1182/blood-2008-01-132068
   PubMed Web of Science ®Google Scholar
• Glogauer M, Marchal CC, Zhu F, Worku A, Clausen BE, Foerster, I, Marks, P, Downey, GP, Dinauer, M, Kwiatkowski, DJ. Rac1 deletion in mouse neutrophils has selective effects on neutrophil functions. J Immunol 2003; 170: 5652–5657.
   PubMed Web of Science ®Google Scholar
• Sun CX, Downey GP, Zhu F, Koh AL, Thang H, Glogauer, M. Rac1 is the small GTPase responsible for regulating the neutrophil chemotaxis compass. Blood 2004; 104: 3758–3765. doi:10.1182/blood-2004-03-0781
   PubMed Web of Science ®Google Scholar
• McCarty OJ, Larson MK, Auger JM, Kalia N, Atkinson BT, Pearce, AC, Ruf, S, Henderson, RB, Tybulewicz, Victor LJ, Machesky, LM, Watson, SP. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem 2005; 280: 39474–39484. doi:10.1074/jbc.M504672200
   PubMed Web of Science ®Google Scholar
• Vidal C, Geny B, Melle J, Jandrot-Perrus M, Fontenay-Roupie M. Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 2002; 100: 4462–4469. doi:10.1182/blood.V100.13.4462
   PubMed Web of Science ®Google Scholar
• Aslan JE, McCarty OJ. Regulation of the mTOR-Rac1 axis in platelet function. Small GTPases 2012; 3: 67–70. doi:10.4161/sgtp.19137
   PubMedGoogle Scholar
• Delaney MK, Liu J, Zheng Y, Berndt MC, Du X. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Arterioscler Thromb Vasc Biol 2012; 32: 2761–2768. doi:10.1161/ATVBAHA.112.254920
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Y, Wang Y, Li D, Zhang L, Wang, K, Luo, X, Yang, Z, Wu, Yi, Liu, J. PDK1 regulates platelet activation and arterial thrombosis. Blood 2013; 121: 3718–3726. doi:10.1182/blood-2012-10-461897
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–646.
   PubMed Web of Science ®Google Scholar
• Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med 2000; 191: 1611–1616.
   PubMed Web of Science ®Google Scholar
• Levay M, Krobert KA, Wittig K, Voigt N, Bermudez M, Wolber, G, Dobrev, D, Levy, FO, Wieland, T. NSC23766, a widely used inhibitor of Rac1 activation, additionally acts as a competitive antagonist at muscarinic acetylcholine receptors. J Pharmacol Exp Ther 2013; 347: 69–79. doi:10.1124/jpet.113.207266
   PubMed Web of Science ®Google Scholar
• Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000; 95: 1317–1323.
   PubMed Web of Science ®Google Scholar
• Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995; 21: 217–231; discussion 231a.
   PubMed Web of Science ®Google Scholar
• Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999; 82: 794–800.
   PubMed Web of Science ®Google Scholar
• Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205–18212.
   PubMed Web of Science ®Google Scholar
• Horstman LL, Jy W, Schultz DR, Mao WW, Ahn YS. Complement-mediated fragmentation and lysis of opsonized platelets: ender differences in sensitivity. J Lab Clin Med 1994; 123: 515–525.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Bhardwaj A, Alam S, Misra R. Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 189–192.
   PubMed Web of Science ®Google Scholar
• Aslan JE, Tormoen GW, Loren CP, Pang J, McCarty OJ. S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. Blood 2011; 118: 3129–3136. doi:10.1182/blood-2011-02-331579
   PubMed Web of Science ®Google Scholar
• Dutting S, Heidenreich J, Cherpokova D, Amin E, Zhang SC, Ahmadian, MR, Brakebusch, C, Nieswandt, B. Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets. J Thromb Haemost 2015; 13: 827–838. doi:10.1111/jth.12861
   PubMed Web of Science ®Google Scholar
• Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004; 101: 7618–7623. doi:10.1073/pnas.0307512101
   PubMed Web of Science ®Google Scholar
• Abreu JR, Dontje W, Krausz S, de Launay D, van Hennik PB, van Stalborch, A-M, ten Klooster, J-P, Sanders, ME, Reedquist, KA, Hordijk, PL, Vervoordeldonk, MJ, Tak, PP. A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 2010; 12: R2. doi:10.1186/ar2900
   PubMed Web of Science ®Google Scholar